-
Most Popular
Search Results
240 results for etp
TELL Stock Earnings: Tellurian Meets EPS for Q2 2024
TELL stock results show that Tellurian met analyst estimates for earnings per share the second quarter of 2024.
AVGO Stock Alert: How Broadcom Could Pave a Path to New Highs
With AVGO stock ready to hit new highs, discover why it is a top pick to capitalize on the semiconductor sector’s recovery.
YMM Stock Earnings: Full Truck Alliance Co Beats EPS, Misses Revenue for Q2 2024
YMM stock results show that Full Truck Alliance Co beat analyst estimates for earnings per share but missed on revenue for the second quarter of…
SQM Stock Earnings: Sociedad Quimica Y Minera Misses EPS, Misses Revenue for Q2 2024
SQM stock results show that Sociedad Quimica Y Minera missed analyst estimates for earnings per share and missed on revenue for the second quarter of…
RRGB Stock Earnings: Red Robin Gourmet Burgers Misses EPS, Beats Revenue for Q2 2024
RRGB stock results show that Red Robin Gourmet Burgers missed analyst estimates for earnings per share but beat on revenue for the second quarter of…
3 Lithium Stocks to Buy on the Dip: August 2024
Lithium stocks may be some of the most hated investments at the moment. But that gives us even more reason to buy.
Future Vehicles Spotlight: 3 Reasons to Buy CARZ ETF on the Dip
The First Trust S-Network Future Vehicles & Tech ETF has tracked a new index since January 2022, and the CARZ ETF is likely to benefit.
PPBT Stock Earnings: Purple Biotech Beats EPS for Q2 2024
PPBT stock results show that Purple Biotech beat analyst estimates for earnings per share the second quarter of 2024.
MAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q2 2024
MAIA stock results show that MAIA Biotechnology missed analyst estimates for earnings per share the second quarter of 2024.
CVM Stock Earnings: CEL-SCI Misses EPS for Q3 2024
CVM stock results show that CEL-SCI missed analyst estimates for earnings per share the third quarter of 2024.
CRGX Stock Earnings: Cargo Therapeutics Beats EPS for Q2 2024
CRGX stock results show that Cargo Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
NTBL Stock Earnings: Notable Labs Misses EPS for Q2 2024
NTBL stock results show that Notable Labs missed analyst estimates for earnings per share the second quarter of 2024.
Q3’s Rising Stars: 7 Lithium Stocks for Your Must-Watch List
Lithium stocks to watch have been devastated. But with a good deal of “excessive pessimism” now priced in, it’s time to buy.
7 Divine Dividend Stocks to Buy for Another Market Crash
Dividend stocks have proved remarkably resilient even during severe market downturns, making them perfect additions to your portfolio.
SDST Stock Earnings: Stardust Power Misses EPS for Q2 2024
SDST stock results show that Stardust Power missed analyst estimates for earnings per share the second quarter of 2024.
VERB Stock Earnings: Verb Tech Beats EPS for Q2 2024
VERB stock results show that Verb Tech beat analyst estimates for earnings per share the second quarter of 2024.
What Are the Hottest Semiconductor Stocks Right Now? 3 Top Picks.
With the AI story heating up, buy semiconductor stocks on the cheap. After a pullback, many are now wildly oversold.
TIMB Stock Earnings: TIM Beats EPS, Beats Revenue for Q2 2024
TIMB stock results show that TIM beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
AFYA Stock Earnings: Afya Beats EPS, Beats Revenue for Q2 2024
AFYA stock results show that Afya beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
ITP Stock Earnings: IT Tech Packaging Reported Results for Q2 2024
IT Tech Packaging just reported results for the second quarter of 2024.
3 Blockchain Stocks to Sell Before the Crypto Winter of 2024
Here are three blockchain stocks to sell, as they face significant risks with a potential crypto winter looming on the horizon in 2024.
TEM Stock Earnings: Tempus AI Beats EPS, Beats Revenue for Q2 2024
TEM stock results show that Tempus AI beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q2 2024
SBFM stock results show that Sunshine Biopharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
6 – 10 of 240 results
